• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国家乳腺癌手术辅助项目的病理研究结果。与雌激素和孕激素受体一致及不一致情况的相关性。

Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors.

作者信息

Fisher E R, Sass R, Fisher B

出版信息

Cancer. 1987 May 1;59(9):1554-9. doi: 10.1002/1097-0142(19870501)59:9<1554::aid-cncr2820590904>3.0.co;2-b.

DOI:10.1002/1097-0142(19870501)59:9<1554::aid-cncr2820590904>3.0.co;2-b
PMID:3828955
Abstract

Pathologic materials were available for review from 1597 women with Stage II (positive regional node metastases) invasive breast cancer in whom estrogen receptor (ER) and progesterone receptor (PR) assays of the primary tumor were performed. These women were enrolled in a clinical trial comparing the effect of postmastectomy adjuvant L-phenylalanine mustard (L-PAM) and 5-fluorouracil (5-FU) with and without tamoxifen (NSABP Protocol No. 9). Significant pathologic and clinical associations with receptor status were similar for both ER and PR except that the latter, unlike ER, was not related to patient age. Regression analyses revealed that the most significant pathologic features related to a concordant positive ERPR receptor status was low (well differentiated) nuclear and histologic grades, slight or absent tumor lymphoid infiltrate, slight or absent necrosis and moderate or marked elastica in decreasing order of importance. All of the factors enumerated are directly or indirectly related to tumor differentiation. Recognition of four or five conforming pathologic features allows for the prediction of either ER or PR status in 70% to 80% of instances respectively, and the presence of three features in 69%. This latter figure is similar to that of estimation of nuclear grade alone. Thirty percent of ERPR estimates were discordant i.e., either ER-PR+ or ER+PR-. Pathologic features associated with discordant assays were not similar to those found when the ERPR estimates were concordant. Life table analyses revealed patients with discordant receptors to exhibit disease-free survival intermediate to that of those with ER+PR+ and ER-PR- values. This information suggests that a discordant receptor status is more reflective of an aberration of ER metabolism than a methodologic error. Histograms correlating frequency of nuclear grades with levels of ER and PR were comparable and revealed patterns indicating the propriety of relating values less than 10 fm/mg as being receptor negative. The frequency of well-differentiated nuclei increased with ascending levels of ER and PR.

摘要

对1597例II期(区域淋巴结转移阳性)浸润性乳腺癌女性患者的病理材料进行了回顾,这些患者均接受了原发肿瘤的雌激素受体(ER)和孕激素受体(PR)检测。这些女性参与了一项临床试验,比较了乳房切除术后辅助使用左旋苯丙氨酸氮芥(L-PAM)和5-氟尿嘧啶(5-FU)加或不加他莫昔芬的效果(NSABP协议编号9)。除PR与患者年龄无关(与ER不同)外,ER和PR与受体状态的显著病理和临床关联相似。回归分析显示,与ERPR受体状态一致呈阳性最显著的病理特征按重要性递减顺序为低(高分化)核级和组织学分级、轻微或无肿瘤淋巴细胞浸润、轻微或无坏死以及中度或显著弹性组织,所有列举的因素均直接或间接与肿瘤分化相关。识别出四或五个符合的病理特征分别可在70%至80%的病例中预测ER或PR状态,识别出三个特征的情况占69%。后一数字与单独估计核级的数字相似。30%的ERPR估计结果不一致,即要么ER-PR+要么ER+PR-。与不一致检测相关的病理特征与ERPR估计结果一致时发现的特征不同。生命表分析显示,受体不一致的患者无病生存期介于ER+PR+和ER-PR-值的患者之间。该信息表明,不一致的受体状态更反映ER代谢异常而非方法学错误。将核级频率与ER和PR水平相关的直方图具有可比性,揭示了表明将小于10 fm/mg的值视为受体阴性合理的模式。高分化核的频率随ER和PR水平升高而增加。

相似文献

1
Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors.国家乳腺癌手术辅助项目的病理研究结果。与雌激素和孕激素受体一致及不一致情况的相关性。
Cancer. 1987 May 1;59(9):1554-9. doi: 10.1002/1097-0142(19870501)59:9<1554::aid-cncr2820590904>3.0.co;2-b.
2
Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.雌激素受体阳性、人表皮生长因子受体2阴性乳腺癌的淋巴结转移灶中孕激素受体表达缺失与他莫昔芬治疗后复发相关。
J Clin Pathol. 2017 Nov;70(11):954-960. doi: 10.1136/jclinpath-2016-204304. Epub 2017 Apr 17.
3
Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.
J Clin Oncol. 1986 Apr;4(4):459-71. doi: 10.1200/JCO.1986.4.4.459.
4
Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.乳腺癌中雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER-2/neu,即C-erb B 2)反应模式与组织学分级、肿瘤大小及淋巴结状态的比较
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.
5
Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.雌激素受体阴性、孕激素受体阳性乳腺癌:临床预后较差。
Arch Pathol Lab Med. 1996 Oct;120(10):970-3.
6
Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.肿瘤雌激素和孕激素受体水平对原发性乳腺癌中他莫昔芬及化疗反应的影响。
J Clin Oncol. 1983 Apr;1(4):227-41. doi: 10.1200/JCO.1983.1.4.227.
7
Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.
J Clin Oncol. 2001 Jan 1;19(1):18-27. doi: 10.1200/JCO.2001.19.1.18.
8
Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy.
Breast Cancer Res Treat. 1983;3(4):355-64. doi: 10.1007/BF01807588.
9
Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.
J Clin Oncol. 1988 Jul;6(7):1076-87. doi: 10.1200/JCO.1988.6.7.1076.
10
Do clinical features and survival of single hormone receptor positive breast cancers differ from double hormone receptor positive breast cancers?单激素受体阳性乳腺癌与双激素受体阳性乳腺癌的临床特征和生存率是否存在差异?
Asian Pac J Cancer Prev. 2014;15(18):7959-64. doi: 10.7314/apjcp.2014.15.18.7959.

引用本文的文献

1
Estrogen receptors genotypes and canine mammary neoplasia.雌激素受体基因型与犬乳腺肿瘤。
BMC Vet Res. 2019 Sep 10;15(1):325. doi: 10.1186/s12917-019-2062-y.
2
Canine mammary tumors as a model for human disease.犬乳腺肿瘤作为人类疾病的模型。
Oncol Lett. 2018 Jun;15(6):8195-8205. doi: 10.3892/ol.2018.8411. Epub 2018 Apr 2.
3
Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.在单一的他莫昔芬治疗的乳腺癌队列中对三种商业孕激素受体检测方法的评估。
Mod Pathol. 2016 Dec;29(12):1492-1500. doi: 10.1038/modpathol.2016.151. Epub 2016 Aug 26.
4
Charity Hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional disease.慈善医院对局限性或区域性乳腺癌患者长期生存及预后因素的经验。
Ann Surg. 1988 May;207(5):569-80. doi: 10.1097/00000658-198805000-00011.
5
Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states.雌性犬乳腺组织中的雌激素(ER)和孕激素受体(PR):非恶性和恶性状态下不同的受体特征
Br J Cancer. 1988 Nov;58(5):594-9. doi: 10.1038/bjc.1988.266.
6
Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry.乳腺癌的核仁分级。关于核仁的频率和定位与组织学、分期、激素受体状态及凝集素组织化学的比较研究。
Virchows Arch A Pathol Anat Histopathol. 1989;415(6):501-8. doi: 10.1007/BF00718643.
7
Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.β2-微球蛋白、MHC I类和II类抗原表达在乳腺癌中缺乏预后意义。
Br J Cancer. 1990 Aug;62(2):289-95. doi: 10.1038/bjc.1990.280.
8
Medullary cancer of the breast revisited.乳腺髓样癌再探讨。
Breast Cancer Res Treat. 1990 Oct;16(3):215-29. doi: 10.1007/BF01806330.